Genetic Testing Market – Growth, Trends, Impact of COVID-19 and Forecast (2022



The genetic testing market was valued at 14,791.51 Million US {Dollars} in 2021 and is anticipated to register a compound annual development fee of roughly 10.81% through the forecast interval (2022-2027). The COVID-19 pandemic has had a major influence on the expansion of the genetic testing market through the disaster.

NEW YORK, June 07, 2022 (GLOBE NEWSWIRE) – declares the discharge of “Genetic Testing Market – Development, Traits, Affect of COVID-19, Forecast (2022 – 2030)” –
In response to the analysis article printed in Genetics in Medication 2020, all medical genetic testing has been restricted and telemedicine-based counseling and counseling has been accredited globally. In response to this examine, 112 antenatal and 156 medical gene/most cancers sufferers have been evaluated in a one-month interval at Columbia College Irving Medical Middle (CUIMC). Most genetic testing companies have adopted virtualization, together with a house testing equipment/dwelling pattern assortment, to fight transmission of SARS-CoV2. Nevertheless, in line with a analysis article printed within the Journal of Medical Genetics 2020, limitations to accessing genetic blood drawing assessments have been reported, with genetic testing being considerably affected, with genetic testing dropping from 97.7% to 74.1%. % noticed through the digital care interval. Thus, COVID-19 is anticipated to have a direct and oblique influence on the genetic testing market through the interval of ongoing disaster.

Furthermore, the growing technological developments from the previous few years have opened up many alternatives for market growth. The rise within the prevalence of continual ailments and the event of check kits for specialised therapeutic areas are aiding the speedy development of the market. In response to the United Nations Indicators on World Inhabitants Prospects for 2020, there will probably be greater than 1.5 billion folks over 65 years of age by 2050, up from 727 million in 2020. Elevated demand for preventive prognosis, particularly genetic testing.

The growing focus by governments in varied nations, on regulating and creating consciousness concerning genetic testing, has led to quicker adoption of those assessments worldwide. Elevated funding for analysis and improvement, mixed with a powerful market presence by main market gamers, has created a powerful entry barrier for brand new entrants. Innovation in product design, high quality enchancment and powerful distribution partnerships are key components to sustaining a aggressive benefit available in the market. For instance, in August 2020, Ricoh Firm Ltd and DNA Chip Analysis Inc. RICOH Customary DNA Collection EGFR Type001 mutation, a reference DNA panel utilized in blood-based genetic testing within the prognosis of lung most cancers.

Adoption of direct-to-consumer genetic testing kits in nations similar to the USA, China and Japan is rising quickly. With growing know-how adoption, consciousness packages, and decrease prices, the marketplace for DTC-GT (Direct Client Genetic Testing) kits is prone to expertise a major increase through the forecast interval. Furthermore, untapped nations similar to India and different creating nations are anticipated to current a profitable alternative for gamers seeking to set up their base within the genetic testing market.

Therefore, as a result of growing burden of continual ailments, technological developments and inclination in the direction of customized medication are anticipated to drive vital development within the genetic testing market through the forecast interval.

Main market tendencies

The genetic testing market is anticipated to dominate the most cancers sector through the forecast interval

Genetic testing helps decide the danger of creating several types of cancers throughout an individual’s lifetime. Genetic assessments can be found to check for inherited variants and mutations within the DNA sequence, which may result in extreme cell development and result in tumor/most cancers. For instance, genetic testing to find out PALB2 (related to elevated dangers of breast and pancreatic most cancers), CHEK2 (breast and colorectal most cancers), BRIP1 (ovarian most cancers), RAD51C and RAD51D (ovarian most cancers).

In response to the analysis examine printed in Medical Most cancers Analysis 2020, COVID-19 is anticipated to reshape oncology apply, medical trials, diagnoses, and the supply of most cancers care to sufferers, which may last more than the brief to medium time period. Pandemic lively, subsequently, COVID-19 is anticipated to influence the market through the pandemic period.

The rising burden of most cancers worldwide and the rising consciousness among the many international inhabitants concerning preventive prognosis and customized medication are the main components driving the most cancers section market through the forecast interval. In response to Globocan 2020, there have been an estimated 19,292,789 new most cancers circumstances in 2020, with roughly 9,958,133 deaths from cancers. As well as, the incidence of recent cancers is estimated to achieve 30.2 million by 2040, in line with the Worldwide Company for Analysis on Most cancers (IARC). Thus, genetic testing helps present details about whether or not most cancers runs within the household and the danger components related to the event of cancers sooner or later amongst people with a household historical past of most cancers. Genetic testing can also be carried out on sufferers who don’t reply to chemotherapy to find out the presence of acquired mutations in treatment-resistant tumors.

Additionally, growing technological developments and product launches are anticipated to drive the studied section. For instance, in December 2020, Roche launched the Cobas PIK3CA mutation check to detect PIK3CA mutations in sufferers with superior or metastatic breast most cancers. Therefore, as a result of components talked about above, the Most cancers section is anticipated to expertise vital development through the forecast interval.

North America captured the biggest market share and is anticipated to retain its dominance through the forecast interval

The genetic testing market is presently dominated by North America, because of components such because the elevated demand for customized genetic testing companies within the area and the growing prevalence of continual and genetic issues.

In response to Globocon 2020, there have been 2,281,658 new most cancers circumstances recognized in the USA in 2020, with 612,390 deaths. Amongst all cancers, breast most cancers had the best incidence with 253,465 circumstances, adopted by lung (227.875), prostate (209.512), and colon (101809) cancers.

In response to the Facilities for Illness Management and Prevention (CDC), most clinics and hospitals have restricted in-person provision of non-essential well being care companies, together with genetic counseling, to cut back transmission of the coronavirus. Nevertheless, suspending genetic counseling can pose difficulties, as a result of if genetic testing isn’t completed on time, it should have an effect on decision-making throughout being pregnant or about most cancers therapy. Therefore, though the studied market is presently slowing down as a result of ongoing pandemic, the scenario is anticipated to steadily enhance.

Elevated product approvals by the US Meals and Drug Administration (FDA) and subsequent launches, along with a excessive focus of main gamers concerned in analysis actions to innovate new genetic testing merchandise, are anticipated to drive market development in North America. For instance, in November 2020, Basis Medication Inc. FDA approval of the FoundationOne Liquid CDx Subsequent-Technology Liquid Pattern Sequence-Based mostly Take a look at as a companion diagnostic machine for the identification of a number of biomarkers in cancers. Moreover, in August 2020, the Dana-Farber Most cancers Institute launched the BRCA and Associated Genes Middle for the prevention and therapy of BRCA-related cancers. Therefore, as a result of growing incidence of most cancers and the methods taken by the main gamers within the area, the genetic testing market is anticipated to develop considerably through the forecast interval in North America.

Aggressive scene

The genetic testing market could be very aggressive and consists of many main gamers. By way of market share, few main gamers presently dominate the market. The presence of main gamers available in the market, similar to Abbott Laboratories, Biorad Laboratories Inc, F. Hoffmann La Roche and Illumina Inc, will increase the general aggressive competitors available in the market. Product developments and enhancements in genetic testing platforms by main gamers are growing the aggressive edge. As well as, key gamers interact in strategic alliances, similar to acquisitions and partnerships, with firms that complement their product portfolio to broaden their presence globally. For instance, in September 2020, Illumina entered right into a definitive settlement to amass GRAIL for Portfolio Enlargement: a multiplex transformative assay (primarily based on Subsequent Technology Sequencing (NGS)).

Extra advantages:

Market Estimate Sheet (ME) in Excel format
3 months of analyst help
Learn the total report:

Round Reportlinker
ReportLinker is an award successful market analysis answer. Reportlinker finds and organizes the most recent trade knowledge so you’ve all of the market analysis you want – immediately, in a single place.


CONTACT: Clare: US: (339)-368-6001 Intl: +1 339-368-6001